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ABSTRACT
Objectives Major ECG abnormalities have been 
associated with increased risk of cardiovascular disease 
(CVD) burden in asymptomatic populations. However, sex 
differences in occurrence of major ECG abnormalities have 
been poorly studied, particularly across ethnic groups. The 
objectives were to investigate (1) sex differences in the 
prevalence of major and, as a secondary outcome, minor 
ECG abnormalities, (2) whether patterns of sex differences 
varied across ethnic groups, by age and (3) to what extent 
conventional cardiovascular risk factors contributed to 
observed sex differences.
Design Cross- sectional analysis of population- based 
study.
Setting Multi- ethnic, population- based Healthy Life in an 
Urban Setting cohort, Amsterdam, the Netherlands.
Participants 8089 men and 11 369 women of Dutch, 
South- Asian Surinamese, African Surinamese, Ghanaian, 
Turkish and Moroccan origin aged 18–70 years without 
CVD.
Outcome measures Age- adjusted and multivariable 
logistic regression analyses were performed to study sex 
differences in prevalence of major and, as secondary 
outcome, minor ECG abnormalities in the overall 
population, across ethnic groups and by age- groups 
(18–35, 36–50 and >50 years).
Results Major and minor ECG abnormalities were less 
prevalent in women than men (4.6% vs 6.6% and 23.8% 
vs 39.8%, respectively). After adjustment for conventional 
risk factors, sex differences in major abnormalities were 
smaller in ethnic minority groups (OR ranged from 0.61 in 
Moroccans to 1.32 in South- Asian Surinamese) than in the 
Dutch (OR 0.49; 95% CI 0.36 to 0.65). Only in South- Asian 
Surinamese, women did not have a lower odds than men 
(OR 1.32; 95% CI 0.96 to 1.84). The pattern of smaller 
sex differences in ethnic minority groups was more 
pronounced in older than in younger age- groups.
Conclusions The prevalence of major ECG abnormalities 
was lower in women than men. However, sex differences 
were less apparent in ethnic minority groups. Conventional 
risk factors did not contribute substantially to observed sex 
differences.
INTRODUCTION
The resting ECG is an essential diagnostic 
instrument in patients with symptoms 
suggestive of cardiovascular disease (CVD).1 
Previous studies show that the occurrence of 
major ECG abnormalities is also associated 
with increased risk of CVD morbidity2 3 and 
mortality3 4 in asymptomatic populations. 
However, differences in the occurrence of 
major ECG abnormalities in men and women 
have been poorly studied. Insights in these 
sex differences may help to identify subpop-
ulations with a future CVD burden and thus 
aid targeted (preventive) therapy.
Although studies have described the prev-
alence of major ECG abnormalities in men 
and women from diverse general popula-
tions,5–11 only three studied sex differences in 
general populations specifically.5–7 Whether 
the occurrence of ECG abnormalities differs 
by sex, independently of cardiovascular risk 
factors, is a topic of ongoing debate. Two 
Strengths and limitations of this study
 ► Participants were sampled from the municipali-
ty registry and reflect a general population sam-
ple of adults of the major ethnic groups living in 
Amsterdam.
 ► Large sample sizes permit the study of sex differ-
ences within each ethnic group, including across 
age strata.
 ► Single ECG measurements of 10 s without addi-
tional imaging techniques (eg, echocardiography) 
may be suboptimal for the measurement of ECG 
abnormalities.
 ► The classification of ‘major’ and ‘minor’ ECG abnor-
malities may depend on criteria used, which may 
affect reported prevalence estimates.
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studies suggested that the composite of major ECG abnor-
malities (eg, atrial fibrillation, Q- wave or T- wave abnor-
malities) is more prevalent among men than women,5 6 
while another observed no sex differences.7
Differences in the occurrence of ECG abnormalities 
have been observed between ethnic groups living in 
similar contexts.6 8 12 13 However, in Europe, the preva-
lence of major ECG abnormalities among ethnic minority 
populations at high risk for CVD, such as men and women 
of South- Asian origin,14 is unknown. Additionally, it is 
unknown to what extent major ECG abnormalities vary 
between men and women across ethnic groups.
The prevalence of ECG abnormalities tends to increase 
with increasing age.5 As larger sex differences in occur-
rence of CVD have been found in younger age- groups 
compared with older age- groups,15 sex differences in 
prevalence of ECG abnormalities may also vary by age.
In this study, we investigated sex differences in the prev-
alence of major and, as a secondary outcome, minor ECG 
abnormalities, in a multi- ethnic population aged 18–70 
years living in Amsterdam, the Netherlands. We assessed 
whether patterns of sex differences varied across ethnic 
groups, overall and by age, and to what extent conven-
tional cardiovascular risk factors contributed to observed 
sex differences, overall and within subgroups.
METHODS
We used baseline data from the Healthy Life in an Urban 
Setting (HELIUS) study, a multi- ethnic cohort study 
conducted in Amsterdam, the Netherlands. The HELIUS 
study has been described in detail elsewhere.16 17 Briefly, 
baseline data collection took place between 2011 and 
2015 and included participants of Dutch, South- Asian 
Surinamese, African Surinamese, Ghanaian, Moroccan 
and Turkish origin aged 18–70 years living in Amsterdam. 
Potential participants were sampled with a simple random 
sampling method from the municipality registry, after 
stratification by ethnicity as defined by registered country 
of birth.18 Data were obtained by questionnaire and phys-
ical examinations (including biological samples). The 
HELIUS study has been approved by the AMC Ethical 
Review Board. All participants provided written informed 
consent.
ECG measurements
Standard 12- lead ECGs were recorded in supine position 
with a GE MAC5500 ECG at 500 samples/s and analysed 
using the Modular ECG Analysis System (MEANS).19 The 
measurement of ECG abnormalities has been described 
in detail elsewhere.20 Briefly, ECG abnormalities were 
assessed by combining ECG diagnoses of the MEANS 
programmes with Minnesota coding, Marquette 12SL 
ECG analysis software and a cardiologist’s interpretation. 
In case of discrepancies, ECGs were double checked. We 
classified ECG abnormalities into major and minor ECG 
abnormalities, based on previous research7 and consensus 
discussion among experts (online supplementarhy 
appendix table 1). This classification was completed prior 
to data analysis.
Ethnicity
Ethnicity was defined by the individual’s country of birth 
combined with the parental countries of birth.18 Suri-
namese participants were further classified according to 
self- reported ethnic origin into ‘African’, ‘South- Asian’, 
‘Javanese’ or ‘other’.
Covariables
Family history of CVD was defined by a self- reported CVD 
diagnosis among first degree family members aged <60 
years. Smoking was classified as current, past or never 
smoker. For current smokers, the number of pack- years 
of smoking was calculated by multiplying the number of 
packs (containing 20 cigarettes or equivalent rates for 
cigars and pipe tobacco) smoked a day by the number of 
years smoked. Physical activity was defined as achieving 
≥30 min of moderate- intensity or high- intensity activity 
per day on ≥5 days per week.21 Alcohol consumption (on 
average in the last 12 months) was classified as: none or 
low (men: 0–4; women: 0–2 beverages/week), moderate 
(men: 5–14; women: 3–7 beverages/week) and high 
(men: >14; women: >7 beverages/week).
Body mass index (BMI) was calculated in duplicate as 
weight (kg) divided by height squared (m2). Blood pres-
sure (BP) was measured in duplicate using a validated 
automated digital BP device (WatchBP Home; Microlife 
AG) in a seated position after ≥5 min of rest. Hyperten-
sion was defined as systolic BP ≥140 mm Hg, diastolic BP 
≥90 mm Hg, use of antihypertensive medication treat-
ment and/or self- reported hypertension.
Fasting blood samples were drawn to determine creat-
inine, lipid and glucose concentrations (details on these 
measurements have been described elsewhere).22 Chronic 
kidney disease (CKD) risk was categorised according to 
the risk of progression of kidney disease based on esti-
mated glomerular filtration rate and albuminuria levels23: 
(1) low, (2) moderately increased and (3) high and very 
high risk. Hypercholesterolemia was defined as total 
cholesterol ≥5.0 mmol/L, high- density lipoprotein choles-
terol <1.0 mmol/L (men) or <1.2 mmol/L (women), 
low- density lipoprotein cholesterol ≥3.0 mmol/L (Frie-
dewald formula24), triglycerides ≥1.7 mmol/L, use of 
lipid- lowering medication and/or self- reported hyper-
cholesterolemia. Participants were considered to have 
diabetes in case of a fasting glucose ≥7.0 mmol/L, use of 
glucose- lowering medication and/or if they reported to 
be diagnosed with diabetes by a doctor.
Study population
Baseline data were available for 22 165 participants. We 
excluded those of Javanese Surinamese (n=233), unknown 
Surinamese (n=267) origin and with another/unknown 
ethnic origin (n=48). Next, we excluded participants with 
a history of CVD (n=1610; based on self- reported prior 
myocardial infarction, cerebrovascular accident (CVA), 
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angioplasty or bypass surgery (on heart or legs), use of 
antiplatelet drugs (Anatomical Therapeutic Chemical 
(ATC) code B01AC), use of oral anticoagulants (ATC 
codes B01AA, B01AE, B01AF), use of antiarrhythmic 
agents (ATC codes C01A, C01B, C07AA07, C08D), or 
paced rhythms). Finally, we excluded participants with 
missing ECG data (n=337) or with missing data on ≥1 
covariables (n=212), resulting in a study population of 
19 458 participants (online supplementary appendix 
figure 1).
Statistical analyses
Baseline characteristics were expressed as means (SD) 
or frequencies (percentages) by sex in the total popula-
tion and per ethnic group. The age- adjusted prevalence 
of any major ECG abnormality, any minor ECG abnor-
mality and a selection of common ECG abnormalities (ie, 
major ECG abnormalities with a prevalence of ≥1% and 
the top 5 most prevalent minor ECG abnormalities) was 
calculated by sex, in the total population and by ethnicity, 
using the study population as the standard. For reference, 
the overall prevalence of less common ECG abnormali-
ties is also provided, but only by sex in the total popula-
tion. The prevalence of any major ECG abnormalities was 
also calculated by age- groups (ie, 18–35, 36–50 and >50 
years based on tertiles of the age distribution in the total 
population) for all ethnic groups.
We performed binary logistic regression analyses with 
hierarchal models to examine sex differences in preva-
lence of (1) any major ECG abnormalities and (2) any 
minor ECG abnormalities, adjusted for age and ethnicity 
(model 1), and additionally for hypertension, hypercho-
lesterolemia, diabetes and smoking status (model 2) to 
determine to what extent conventional cardiovascular 
risk factors contributed to observed differences. We also 
examined the additional contribution of other well- 
known cardiovascular risk factors, that is, family history of 
CVD and CKD risk (model 3) and BMI, alcohol consump-
tion and physical activity (model 4). To study whether the 
sex differences varied between ethnic groups (ie, effect 
modification), a statistical interaction term for sex and 
ethnicity on a multiplicative scale was added. Then, the 
main analyses (model 2 with interaction term) for major 
ECG abnormalities were repeated stratified by age- groups 
(18–35, 36–50 and >50 years) to examine the consis-
tency of sex differences across ethnic groups among age- 
groups. All statistical analyses were performed in R studio 
V.1.1.453.25 P values <0.05 were regarded as statistically 
significant.
Sensitivity analyses
We repeated the main analyses excluding obese partici-
pants (BMI >30), since obesity may influence the accu-
racy of ECG measurements.26 Furthermore, use of 
psychotropic medication may induce alterations of the 
ECG resulting in ECG abnormalities (eg, QT prolonga-
tion).27 Therefore, we repeated the analyses excluding 
participants with current use of psychotropic medication. 
Finally, we repeated the analyses using number of pack- 
years of smoking instead of smoking status, to examine 
whether the scale of the variables (numeric vs categor-
ical) altered the results.
Patient and public involvement
There was no specific patient or public involvement in 
the development of the research questions, outcome 
measures, study design and recruitment/conduct of 
the present study. However, for the core HELIUS study, 
several supportive measures were taken to enhance the 
enrolment of ethnic minority groups. For example, 
ethnic- specific communication strategies were used, 
such as working with faith communities (churches and 
mosques) and endorsement from local key figures. Under-
standability of and time to complete the questionnaire 
were also enquired among participants. In addition, the 
present study is part of a larger project on sex and gender 
differences in CVD risk. As part of this project, interviews 
and a short survey on research priority setting according 
to patients with CVD and persons at increased CVD risk 
were conducted. The present study aligns with our find-
ings from these interviews and survey that more research 
on sex and gender differences in CVD was perceived as 
relevant by the target group.
RESULTS
Mean age was around 43 years (SD 13) in women and 
44 years (SD 13) in men (table 1). More than 20% 
of both men and women had a family history of CVD. 
Women were less often current smokers and had fewer 
mean pack- years of smoking compared with men, while 
the prevalence of high alcohol consumption was similar 
among men and women. Women had a higher mean 
BMI and were less physically active. Hypertension, hyper-
cholesterolemia and diabetes were less prevalent among 
women than men, while high CKD risk was equally prev-
alent among men and women. Women more often used 
psychotropic medication than men. These patterns in 
baseline characteristics differed across ethnic groups 
(online supplementary appendix table 2).
Overall, the age- adjusted prevalence of major ECG 
abnormalities was lower among women (4.6%) compared 
with men (6.6%; table 2). In most ethnic groups, women 
had a lower age- adjusted prevalence (range: 2.9%–6.1%) 
compared with men (range: 4.7%–7.9%), except in the 
South- Asian Surinamese (7.2% vs 6.0%, respectively). 
Conventional cardiovascular risk factors and other well- 
known risk factors did not contribute substantially to the 
observed sex differences in major ECG abnormalities 
in the total population and within ethnic groups. For 
instance, the OR of having a major ECG abnormality 
changed from 0.69 (95% CI 0.61 to 0.78) to 0.71 (95% 
CI 0.62 to 0.81) among women vs men after adjustment 
for hypertension, hypercholesterolemia, diabetes and 
smoking status, and to 0.67 (95% CI 0.58 to 0.76) after 
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adjustment for family history of CVD, CKD risk, BMI, 
alcohol consumption and physical activity.
There was a general pattern of smaller sex differences 
in occurrence of major ECG abnormalities in the ethnic 
minority groups compared with the Dutch (table 2). The 
adjusted OR for women vs men varied from 0.49 (95% CI 
0.36 to 0.65) in the Dutch to 0.73 (95% CI 0.53 to 1.01) 
in Turkish. Only in the South- Asian Surinamese group, 
women did not have a lower odds than men (adjusted OR 
1.32; 95% CI 0.96 to 1.84).
In the total population, the most frequently observed 
major ECG abnormalities were T- wave abnormalities 
(1.2%), microvoltages (1.2%) and (ECG suggestive of) 
Table 1 Baseline characteristics of 19 458 men and women 
with ECG measurements
Men (n=8089)
Women 
(n=11 369)
Age (years) 43.8 (13.0) 43.1 (13.0)
Ethnicity
  Dutch 1873 (23.2) 2293 (20.2)
  South- Asian Surinamese 1125 (13.9) 1464 (12.9)
  African Surinamese 1411 (17.4) 2266 (19.9)
  Ghanaian 822 (10.2) 1321 (11.6)
  Turkish 1451 (17.9) 1769 (15.6)
  Moroccan 1407 (17.4) 2256 (19.8)
Family history of CVD (missing: 
n=217)
1637 (20.4) 2611 (23.3)
Smoker
  Current 2539 (31.4) 2032 (17.9)
  Past 2021 (25.0) 1753 (15.4)
  Never 3529 (43.6) 7584 (66.7)
Pack- years of smoking 
(missing: n=191)
5.4 (16.2) 1.8 (7.3)
Achieving physical activity 
norm (missing: n=27)
5020 (62.2) 5963 (52.5)
Alcohol consumption (missing: n=115)
  None or low 5981 (74.4) 8985 (79.5)
  Moderate 1526 (19.0) 1549 (13.7)
  High 528 (6.6) 774 (6.8)
BMI (kg/m2; missing: n=15) 26.3 (4.2) 27.5 (5.8)
CKD risk (missing: n=63)
  Low 7684 (95.4) 10 689 (94.3)
  Moderate 304 (3.8) 555 (4.9)
  High 68 (0.8) 95 (0.8)
Hypertension 3026 (37.4) 3594 (31.6)
Hypercholesterolemia 5752 (71.1) 7147 (62.9)
Diabetes 829 (10.2) 952 (8.4)
Use of psychotropic medication 
(missing: n=4)*
397 (4.9) 679 (6.0)
Data are presented as means (SD) or frequencies (%).
*Anatomical Therapeutic Chemical codes: N03AE, N03AF, N03AG, N03AN, 
N05A, N05BA, N05C, N06A, N06BA, N07B and R06AD02.
BMI, body mass index; CKD, chronic kidney disease; CVD, cardiovascular 
disease.
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cardiomyopathy (1.1%) among women and T- wave abnor-
malities (1.6%), right bundle branch block (RBBB; 1.4%) 
and cardiomyopathy (1.1%) among men. Among South- 
Asian Surinamese women, the only group of women with 
no lower odds than men, microvoltages (2.9%), cardio-
myopathy (1.9%) and T- wave abnormalities (1.5%) were 
the most prevalent major ECG abnormalities. T- wave 
abnormalities (1.9%), cardiomyopathy (1.2%) and RBBB 
(1.1%) were the most prevalent major ECG abnormalities 
among South- Asian Surinamese men.
As expected, the prevalence of major ECG abnormali-
ties was higher in older than younger age- groups in both 
men and women (figure 1). The general pattern of smaller 
sex differences in the ethnic minority groups compared 
with the Dutch differed across the age strata (table 3). 
In the older age- groups, the adjusted sex difference in 
the odds of having a major ECG abnormality appeared 
less pronounced in ethnic minorities compared with the 
Dutch, whereas this sex difference appeared more similar 
across ethnic group in the youngest age- group. Whereas 
women in all ethnic groups had a lower odds compared 
with men across all age strata, this was only the case in the 
youngest age- group of South- Asian Surinamese women vs 
men.
Women had a lower prevalence of minor ECG abnor-
malities (range: 16.2%–35.6%) compared with men 
(range: 28.5%–55.7%; online supplementary appendix 
table 3). Sex differences in minor ECG abnormalities 
were similar across ethnic groups, and were not influ-
enced by conventional risk factors.
The prevalence of most common ECG abnormalities 
was also lower in women than men (online supplementary 
appendix table 4A). Only mildly prolonged QTc interval 
was more prevalent in women than in men. Patterns were 
similar across ethnic groups. The prevalence of most less 
common ECG abnormalities was also lower in women 
Figure 1 Prevalence of any major ECG abnormalities in men (A) and women (B) by age- groups and ethnicity.
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than men, except for microvoltages, severely prolonged 
QTc (Bazett) interval, and left bundle branch block, atrial 
rhythm and sinus tachycardia (online supplementary 
appendix table 4B).
Sensitivity analyses did not alter our interpretation of 
findings (data not shown).
DISCUSSION
In our study, women have an overall lower age- adjusted 
prevalence of major ECG abnormalities than men. Sex 
differences in the prevalence of major ECG abnormali-
ties are smaller in the ethnic minority groups than in the 
Dutch, particularly in older age- groups. Differences in 
conventional cardiovascular risk factors and other well- 
known risk factors do not contribute substantially to these 
sex differences.
Our study has limitations. First, the results may be 
affected by selection bias due to non- response (response 
rate: 28%). Non- response analyses showed that women 
were more likely to participate than men, Turks and 
Moroccans were less likely to participate compared 
with other ethnic groups, and participants were slightly 
older than non- participants.17 However, we were able 
to include large numbers of both men and women, 
each ethnic group and age- group, indicating sufficient 
representation of all subgroups. This is relevant because 
previous work has shown that relative differences in 
CVD risk factors between ethnic groups are similar 
to other European countries,28 suggesting that our 
results are generalisable to other European countries. 
Second, the definition of prior CVD was not compre-
hensive, as data on self- reported prior CVD other than 
myocardial infarction and CVA were lacking. However, 
we also excluded participants with a prior angioplasty 
or bypass surgery (on heart or legs), or paced rhythms, 
and those participants using antiplatelet drugs, oral 
Table 3 The odds of major ECG abnormalities in women compared with men by age- groups, in the total population and with 
an interaction term for sex and ethnicity
OR (95% CI) P value Ratio of ORs (95% CI)‡ P value
Aged 18–35 years (n=5870)*
  Overall† 0.38 (0.27 to 0.54) <0.001 NA NA
  Dutch 0.30 (0.14 to 0.60) <0.01 Reference NA
  South- Asian Surinamese 0.48 (0.18 to 1.18) 0.12 1.58 (0.47 to 5.11) 0.45
  African Surinamese 0.38 (0.12 to 1.05) 0.07 1.25 (0.34 to 4.44) 0.73
  Ghanaian 0.48 (0.13 to 1.77) 0.26 1.60 (0.37 to 7.07) 0.52
  Turkish 0.55 (0.28 to 1.09) 0.09 1.84 (0.69 to 5.01) 0.23
  Moroccan 0.23 (0.09 to 0.55) <0.01 0.77 (0.23 to 2.42) 0.65
Aged 36–50 years (n=7099)*
  Overall† 0.89 (0.70 to 1.12) 0.32 NA NA
  Dutch 0.51 (0.28 to 0.90) 0.02 Reference NA
  South- Asian Surinamese 2.61 (1.39 to 5.20) <0.01 5.13 (2.19 to 12.56) <0.001
  African Surinamese 0.49 (0.29 to 0.85) 0.01 0.97 (0.44 to 2.16) 0.94
  Ghanaian 0.91 (0.50 to 1.71) 0.76 1.79 (0.78 to 4.22) 0.18
  Turkish 1.04 (0.64 to 1.69) 0.87 2.04 (0.97 to 4.38) 0.06
  Moroccan 0.92 (0.51 to 1.67) 0.79 1.81 (0.80 to 4.17) 0.16
Aged >50 years (n=6489)*
  Overall† 0.74 (0.62 to 0.89) <0.01 NA NA
  Dutch 0.54 (0.37 to 0.78) <0.01 Reference NA
  South- Asian Surinamese 1.22 (0.79 to 1.91) 0.37 2.27 (1.28 to 4.06) <0.01
  African Surinamese 0.84 (0.59 to 1.18) 0.31 1.55 (0.94 to 2.59) 0.09
  Ghanaian 0.74 (0.46 to 1.17) 0.20 1.37 (0.75 to 2.48) 0.30
  Turkish 0.55 (0.31 to 0.96) 0.04 1.02 (0.51 to 2.00) 0.96
  Moroccan 0.68 (0.40 to 1.16) 0.16 1.26 (0.66 to 2.42) 0.49
*Model adjustment: age, hypertension, hypercholesterolemia, diabetes and smoking status.
†These models were also adjusted for ethnicity.
‡Measure of effect modification on multiplicative scale (statistical interaction term).
NA, not applicable.
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anticoagulants or antiarrhythmic agents and verified 
that our results were consistent in analyses restricted 
to those with a favourable cardiovascular risk profile 
(post hoc analysis in participants without hypertension, 
hypercholesterolemia, diabetes and those not smoking; 
data not shown). Therefore, it is unlikely that our results 
were substantially affected by misclassification. Third, 
single ECG measurements may have been suboptimal 
for the measurement of ECG abnormalities, poten-
tially affecting the prevalence estimates. Some common 
expressions of CVD might not always be detectable by 
a single ECG measurement of 10 s, such as paroxysmal 
atrial fibrillation, and some ECG abnormalities need 
additional diagnostic measurements. However, 24 hours 
ECG monitoring with portable ECG devices and addi-
tional imaging techniques (eg, echocardiography) are 
often not feasible in population- based studies. Finally, 
the classification of ‘major’ and ‘minor’ ECG abnor-
malities depends on criteria used, and may be variable 
given the complexity of detailed ECG interpretation. 
For instance, the level of severity of some abnormalities 
may depend on the full clinical assessment or on combi-
nations of abnormalities (eg, RBBB with left axis devi-
ation). We also did not distinguish between men and 
women, ethnic groups, and age- groups in the assessment 
of the classification of major and minor abnormalities. 
If future research would reveal that the implication of 
abnormalities is different for any of these groups, this 
may influence the magnitude of the observed differ-
ences in our study.
Similar to previous studies reporting on the preva-
lence of composite major ECG abnormalities stratified 
by sex,5–8 10 11 we observed an overall lower prevalence 
of major ECG abnormalities in women compared with 
men in most ethnic groups. Prevalence estimates in both 
men and women were within the range reported in most 
previous studies (range: 3.0%–13.2%),5 6 8 10 except two 
studies with higher estimates.7 11 T- wave abnormalities 
were the most prevalent major ECG abnormalities in 
both men and women in our study and most previous 
studies.5–7 10 11 A much larger heterogeneity has been 
reported in previous studies in prevalence of minor 
ECG abnormalities, ranging from 4.5% to 31.6% in 
women5 6 8 9 11 and from 7.3% to 45.7% in men.5 6 8 9 11 Our 
prevalence was higher compared with most studies, most 
likely due to differences in the classification of major and 
minor ECG abnormalities.
The observed sex differences in major ECG abnormal-
ities are in line with known differences in cardiovascular 
pathophysiology and epidemiology of CVD between men 
and women.29 30 For instance, men tend to develop coro-
nary artery disease (CAD) earlier than women, resulting 
in a higher incidence of CAD in men compared with 
women, in particular at a younger age.29 30 This age- effect 
is consistent with our observations across ethnic groups of 
larger sex differences in prevalence of major ECG abnor-
malities in the youngest age- group compared with the 
older age- groups.
Differential patterning of cardiovascular risk factors did 
not explain the observed sex differences in prevalence 
of major ECG abnormalities overall and across ethnic 
groups. This finding is consistent with two previous 
studies on sex differences in ECG abnormalities5 6 but 
not with another study.7 Other explanations for the rela-
tive cardiovascular advantage of women compared with 
men at a younger age are still unclear, but may relate to 
sex hormones, with a prominent role for the protective 
effects of oestrogen in the development of CVD among 
premenopausal women.29 Our findings of larger sex 
differences in prevalence of major ECG abnormalities 
in the youngest age- group compared with the older age- 
groups support this hypothesis.
We observed that only South- Asian Surinamese women 
did not have a lower odds of having a major ECG abnor-
mality compared with South- Asian Surinamese men, 
which was mainly due to the higher prevalence of major 
ECG abnormalities among South- Asian Surinamese 
women compared with other women. South- Asian popu-
lations living in Europe are already considered a high- 
risk population for CVD14 and our findings may suggest 
that South- Asian Surinamese women specifically are a 
target group for CVD prevention strategies. Although 
women had a consistently lower odds of having a major 
ECG abnormality than men in all other ethnic groups 
(except South- Asian Surinamese), Dutch women had a 
larger cardiovascular advantage than the other women. 
These findings are in line with a previous study from the 
USA showing a larger gap between men and women of 
the white majority population compared with black men 
and women in CAD mortality.31 In contrast, a Dutch study 
on sex disparities in myocardial infarction incidence 
observed a smaller sex difference in the Dutch majority 
population compared with minority populations origi-
nating from Morocco, South- Asia and Turkey.15 Expla-
nations for the discrepancy between this and our study 
are unclear, but may relate to differences in study popula-
tions and exclusion criteria.
Differential patterning of cardiovascular risk factors 
did not explain the smaller cardiovascular advantage 
among minority women compared with Dutch women, 
suggesting that other factors may be relevant. Psycho-
social factors (eg, discrimination), for instance, may be 
important risk factors for major ECG abnormalities in 
some groups of participants, potentially through stress 
and lifestyle- related factors. For instance, an American 
study found that current and chronic stress were asso-
ciated with subclinical atherosclerosis in South- Asian 
women but not in South- Asian men.32 Further research 
needs to confirm whether these psychosocial factors may 
also explain ethnic- specific variation in sex differences in 
occurrence of major ECG abnormalities.
The observed sex differences in occurrence of major 
ECG abnormalities, overall and within subgroups, may 
also reflect that ECG reference values do not differentiate 
between men and women (except QTc duration), ethnic 
groups or age- groups. Normal values for ECGs may differ 
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for women33 and non- white groups34 compared with white 
men, in whom the ECG reference criteria were developed. 
This is problematic since subgroups with pathological 
ECGs and potentially related cardiovascular risk might 
have been missed, or have a false positive diagnosis. For 
example, some studies suggest that current ECG criteria 
for microvoltages may be less valid for women35 and Asian 
populations,36 which may have resulted in an overestima-
tion of the occurrence of microvoltages among South- 
Asian Surinamese women in our study.
In conclusion, we observed sex differences in ECG 
abnormalities and identified subpopulations with a rela-
tively high prevalence, for example, Dutch men, and 
men and women of South- Asian and African origin. 
Given the association of major ECG abnormalities with 
CVD morbidity and mortality,2–4 these groups may partic-
ularly benefit from prevention strategies to reduce the 
future burden of CVD. Moreover, the observed differ-
ences occurred irrespective of conventional risk factors, 
suggesting that opportunities to reduce the burden of 
CVD might be missed if prevention strategies are solely 
targeted at those with conventional risk factors. Previous 
studies have suggested that ECG measures may be, in 
addition to established cardiovascular risk factors, useful 
for the prediction of future CVD in intermediate and 
high- risk groups.37 38 However, evidence is still limited, 
potential harms of screening are unknown, and ECG 
reference values are not sex- specific, ethnic- specific 
and age- specific. Hence, screening for CVD with ECG is 
currently not recommended.39 In future research, ECG 
reference values should be validated in ethnically diverse 
populations of men and women of different age- groups 
in order to further investigate the occurrence of ECG 
abnormalities and the potentially added value of an ECG 
to cardiovascular risk classification.
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